SCHEMBL4850035

SCHEMBL4850035

CCN(CC)CC(O)CNc1ccc(N)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.39
EGFR P00533 1/20 0.39
MAPT P10636 6/20 0.38
TSHR P16473 4/20 0.38
ACHE P22303 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPK1 P28482 3/20 0.38
LMNA P02545 2/20 0.38
SLC22A2 O15244 1/20 0.38
SLC22A1 O15245 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAOA P21397 1/20 0.38
HTR3A P46098 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
BLM P54132 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PMP22 Q01453 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24322415 0.83 MAPT (0.56) BCL2EGFRMAPTTSHRALDH1A1
SCHEMBL2878804 0.81 MAPT (0.43) MAPTALDH1A1MAPK1HTTGAA
SCHEMBL2028408 0.80 MAPT (0.44) MAPTALDH1A1MAPK1LMNACYP2C19
SCHEMBL17459904 0.78 MAPT (0.41) MAPTALDH1A1MAPK1HTTGAA
SCHEMBL4852978 0.77 LMNA (0.38) MAPTTSHRACHEALDH1A1MAPK1
SCHEMBL33651 0.75 MAPT (0.41) MAPTALDH1A1MAPK1CYP2C19MAOA
SCHEMBL4851308 0.75 MAPT (0.41) MAPTALDH1A1MAPK1LMNACYP2C19
SCHEMBL6396649 0.75 CA1 (0.51) ALDH1A1MAPK1CYP2D6CYP3A4GFER
SCHEMBL5155005 0.74 MAPT (0.43) MAPTALDH1A1LMNACYP2C19MAOA
SCHEMBL4953767 0.73 MAPT (0.70) MAPTALDH1A1MAPK1HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435268-B2 N-alkylhydroxylated secondary para-phenylenediamine compounds, composition for dyeing keratin fibers comprising the same, and dyeing processes using the composition L'OREAL S.A. (FR) 2008-10-14 US claimed
US-20060005322-A1 N-alkylhydroxylated secondary para-phenylenediamine compounds, composition for dyeing keratin fibers comprising the same, and dyeing processes using the composition L'OREAL S.A. (FR) 2006-01-12 US claimed
EP-1580185-A1 Secondary n-Alkylhydroxylated p-Phenylendiamins, dye composition for keratin fibers containing them, processes and uses. L'OREAL (FR) 2005-09-28 EP claimed
US-7435268-B2 N-alkylhydroxylated secondary para-phenylenediamine compounds, composition for dyeing keratin fibers comprising the same, and dyeing processes using the composition L'OREAL S.A. (FR) 2008-10-14 US disclosed
US-7435268-B2 N-alkylhydroxylated secondary para-phenylenediamine compounds, composition for dyeing keratin fibers comprising the same, and dyeing processes using the composition L'OREAL S.A. (FR) 2008-10-14 US disclosed
US-7435268-B2 N-alkylhydroxylated secondary para-phenylenediamine compounds, composition for dyeing keratin fibers comprising the same, and dyeing processes using the composition L'OREAL S.A. (FR) 2008-10-14 US disclosed
US-20060005322-A1 N-alkylhydroxylated secondary para-phenylenediamine compounds, composition for dyeing keratin fibers comprising the same, and dyeing processes using the composition L'OREAL S.A. (FR) 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060005322-A1 N-alkylhydroxylated secondary para-phenylenediamine compounds, composition for dyeing keratin fibers comprising the same, and dyeing processes using the composition KRT18, CDC73, PRKDC BCL2 2878/4885EGFR 1135/4885MAPT 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.